Innophos Holdings, Inc. announced that it is expanding its portfolio of co-processed, multifunctional excipients with the launch of A-Tab® MD at the CPhI 2019 tradeshow and expo taking place November 5-7 at the Messe Frankfurt GmbH in Frankfurt, Germany. A-Tab® MD is a label-friendly, multifunctional excipient demonstrated to significantly enhance compressibility and simplify formulations of pharmaceutical and nutraceutical tablets and capsules. As a result, with A-Tab® MD, formulators can improve manufacturing efficiency, increase performance and deliver smaller tablet sizes to meet consumer preferences. With the launch of A-Tab® MD, Innophos further expands its growing portfolio of co-processed, multifunctional excipients that include Nutra-Tab® and Tri-Tab® PVP.